Form 4 for OCGN Ocugen, Inc.
Accepted 2022-03-22 00:00:00 ET · period of report 2022-03-18 · accession 0001062993-22-008356 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-03-22 | 2022-03-18 | OCGN | Crespo Jessica | CAO, SVP, Fin | A - Grant | $0.00 | +22.9K | 40.4K | +131% | $0 |
| D | 2022-03-22 | 2022-03-18 | OCGN | Crespo Jessica | CAO, SVP, Fin | A - Grant | $0.00 | +84.2K | 84.2K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-18 | A | A | 22,940 | $0.00 | 40,440 | D | — | — | (F1) Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Ocugen, Inc's (the "Company's") common stock. The restricted stock units vest annually in three equal installments commencing on March 18, 2023, subject to continued employment with the Company on the applicable vesting dates. The restricted stock units will be settled on each applicable vesting date in shares of the Company's common stock. |
| 2 | Derivative | Option (Right to Buy) | 2022-03-18 | A | A | 84,192 | $0.00 | 84,192 | D | $3.72 · — to 2032-03-18 | 84,192 Common Stock | (F2) The option vests annually in equal installments over three years commencing on March 18, 2023, subject to continued employment with the Company on the applicable vesting dates. |